Adamu A, Li S, Gao F, Xue G (2024) ‘The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets’. Front Aging Neurosci, 16

Al-Bachari S, Naish J, Parker G, Emsley H, Parkes L (2020) ‘Blood-Brain Barrier Leakage Is Increased in Parkinson’s Disease’. Front Physiol, 11

Alexander SK, Rittman T, Xuereb JH, Bak TH, Hodges JR, Rowe JB (2014) Validation of the new consensus criteria for the diagnosis of corticobasal degeneration. J Neurol Neurosurg Psychiatry 85(8):923–927

Article  Google Scholar 

Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, Boxer AL, Dickson DW, Grossman M, Hallett M, Josephs KA, Kertesz A, Lee SE, Miller BL, Reich SG, Riley DE, Tolosa E, Troster AI, Vidailhet M, Weiner WJ (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80(5):496–503

Article  PubMed  PubMed Central  Google Scholar 

Asano T, Ito H, Kariya Y, Hoshi K, Yoshihara A, Ugawa Y, Sekine H, Hirohata S, Yamaguchi Y, Sato S, Kobayashi H, Migita K, Ohira H, Hashimoto Y, Watanabe H (2017) Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus. Plos one 12(10):18

Article  Google Scholar 

Ayton S, Lei P, McLean C, Bush AI, Finkelstein DI (2016) Transferrin protects against parkinsonian neurotoxicity and is deficient in Parkinson’s substantia Nigra. Signal Transduct Target Therapy 1:6

Google Scholar 

Balistreri CR, Monastero R (2023) ‘Neuroinflammation and Neurodegenerative Diseases: How Much Do We Still Not Know?‘. Brain Sci, 14(1)

Bamm VV, Geist AM, Harauz G (2017) Correlation of geographic distributions of haptoglobin alleles with prevalence of multiple sclerosis (MS) - a narrative literature review. Metab Brain Dis 32(1):19–34

Article  PubMed  Google Scholar 

Bhidayasiri R, Rattanachaisit W, Phokaewvarangkul O, Lim TT, Fernandez HH (2019) Exploring bedside clinical features of parkinsonism: A focus on differential diagnosis. Parkinsonism Relat Disord 59:74–81

Article  PubMed  Google Scholar 

Bourel J, Planche V, Dubourdieu N, Oliveira A, Sere A, Ducourneau E, Tible M, Maitre M, Leste-Lasserre T, Nadjar A, Desmedt A, Ciofi P, Oliet S, Panatier A, Tourdias T (2021) ‘Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis’. Neurobiol Dis, 160

Boxer AL, Yu JT, Golbe LI, Litvan I, Lang AE, Hoglinger GU (2017) Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol 16(7):552–563

Article  PubMed  PubMed Central  Google Scholar 

Ceciliani F, Lecchi C (2019) The immune functions of alpha(1) acid glycoprotein. Curr Protein Pept Sci 20(6):505–524

Article  CAS  PubMed  Google Scholar 

Chaubey K, Rao M, Alam S, Waghmare C, Bhattacharya B (2016) Increased expression of immune modulator proteins and decreased expression of Apolipoprotein A-1 and haptoglobin in blood plasma of sarin exposed rats. Chemico-Biol Interact 246:36–44

Article  CAS  Google Scholar 

Chertkow H, Borrie M, Whitehead V, Black S, Feldman H, Gauthier S, Hogan D, Masellis M, McGilton K, Rockwood K, Tierney M, Andrew M, Hsiung G, Camicioli R, Smith E, Fogarty J, Lindsay J, Best S, Evans A, Das S, Mohaddes Z, Pilon R, Poirier J, Phillips N, MacNamara E, Dixon R, Duchesne S, MacKenzie I, Rylett R (2019) The comprehensive assessment of neurodegeneration and dementia: Canadian cohort study, vol 46. Canadian journal of neurological sciences, pp 499–511

Chi X, Yin S, Sun Y, Kou L, Zou W, Wang Y, Jin Z, Wang T, Xia Y (2025) Astrocyte-neuron communication through the complement C3-C3aR pathway in Parkinson’s disease. BRAIN Behav Immun 123:229–243

Article  CAS  PubMed  Google Scholar 

Chiu SY, Wyman-Chick KA, Ferman TJ, Bayram E, Holden SK, Choudhury P, Armstrong MJ (2023) Sex differences in dementia with lewy bodies: focused review of available evidence and future directions. Parkinsonism Relat Disord 107:11

Article  Google Scholar 

Chouliaras L, Thomas A, Malpetti M, Donaghy P, Kane J, Mak E, Savulich G, Prats-Sedano MA, Heslegrave AJ, Zetterberg H, Su L, Rowe JB, O’Brien JT (2022) ‘Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer’s disease, frontotemporal dementia and progressive supranuclear palsy’. J Neurol Neurosurg Psychiatry, pp. 8

Cocciolo A, Di Domenico F, Coccia R, Fiorini A, Cai J, Pierce WM, Mecocci P, Butterfield DA, Perluigi M (2012) Decreased expression and increased oxidation of plasma haptoglobin in alzheimer disease: insights from redox proteomics. Free Radic Biol Med 53(10):1868–1876

Article  CAS  PubMed  Google Scholar 

Costa-Mallen P, Checkoway H, Zabeti A, Edenfield MJ, Swanson PD, Longstreth WT, Franklin GM, Smith-Weller T, Sadrzadehl SMH (2008) The functional polymorphism of the hemoglobin-binding protein haptoglobin influences susceptibility to idiopathic Parkinson’s disease. Am J Med Genet Part B-Neuropsychiatric Genet 147B(2):216–222

Article  CAS  Google Scholar 

Costa-Mallen P, Zabetian CP, Hu SC, Agarwal P, Yearout D, Checkoway H (2016) Smoking and haptoglobin phenotype modulate serum ferritin and haptoglobin levels in Parkinson disease. J Neural Transm 123(11):1319–1330

Article  CAS  PubMed  Google Scholar 

Dignass A, Farrag K, Stein J (2018) Limitations of serum ferritin in diagnosing Iron deficiency in inflammatory conditions. Int J Chronic Dis 2018:pp9394060

Google Scholar 

Dufek M, Hamanova M, Lokaj J, Goldemund D, Rektorova I, Michalkova Z, Sheardova K, Rektor I (2009) Serum inflammatory biomarkers in Parkinson’s disease. Parkinsonism Relat Disord 15(4):318–320

Article  CAS  PubMed  Google Scholar 

Elpek GO (2021) Orosomucoid in liver diseases. World J Gastroenterol 27(45):7739–7747

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garland P, Morton MJ, Haskins W, Zolnourian A, Durnford A, Gaastra B, Toombs J, Heslegrave AJ, More J, Okemefuna AI, Teeling JL, Graversen JH, Zetterberg H, Moestrup SK, Bulters DO, Galea I (2020) Haemoglobin causes neuronal damage in vivo which is preventable by haptoglobin. Brain Commun 2(1):17

Article  Google Scholar 

Gille G, Reichmann H (2011) Iron-dependent functions of mitochondria–relation to neurodegeneration. J Neural Transm (Vienna) 118(3):349–359

Article  CAS  PubMed  Google Scholar 

Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Durr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71(9):670–676

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giri P, Banerjee A, Ghosal A, Layek B (2024) ‘Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications’. Int J Mol Sci, 25

Gregersen E, Betzer C, Kim WS, Kovacs G, Reimer L, Halliday GM, Thiel S, Jensen PH (2021) Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity. J Neuroinflamm 18(1):10

Article  Google Scholar 

Hall S, Janelidze S, Surova Y, Widner H, Zetterberg H, Hansson O (2018) Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders. Sci Rep 8:9

Article  Google Scholar 

Hoglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Muller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI (2017) Litvan, I. and movement disorder Soc-Endorsed, P. Mov Disord 32(6):853–864 ‘Clinical Diagnosis of Progressive Supranuclear Palsy: The Movement Disorder Society Criteria’

PubMed  PubMed Central  Google Scholar 

Hourfar H, Aliakbari F, Aqdam S, Nayeri Z, Bardania H, Otzen D, Morshedi D (2023) The impact of α-synuclein aggregates on blood-brain barrier integrity in the presence of neurovascular unit cells. Int J Biol Macromol 229:305–320

Article  CAS  PubMed  Google Scholar 

Jo M, Kim JH, Song GJ, Seo M, Hwang EM, Suk K (2017) Astrocytic Orosomucoid-2 modulates microglial activation and neuroinflammation. J Neurosci 37(11):2878–2894

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaleta M, Hényková E, Mensíková K, Friedecky D, Kvasnicka A, Klícová K, Konícková D, Strnad M, Kanovsky P, Novák O (2024) Patients with neurodegenerative proteinopathies exhibit altered Tryptophan metabolism in the serum and cerebrospinal fluid. ACS Chem Neurosci 15:582–592

Article  CAS  PubMed  Google Scholar 

Kawabata H (2019) Transferrin and transferrin receptors update. Free Radic Biol Med 133:46–54

Article  CAS  PubMed  Google Scholar 

Konicková D, Mensíková K, Klícová K, Chudácková M, Kaiserová M, Prikrylová H, Otruba P, Nevrly M, Hlustík P, Hényková E, Kaleta M, Friedecky D, Matej R, Strnad M, Novák O, Plihalová L, Rosales R, Colosimo C, Kanovsky P (2023) Cerebrospinal fluid and blood serum biomarkers in neurodegenerative proteinopathies: A prospective, open, cross-correlation study. J Neurochem 167:168–182

Article  PubMed  Google Scholar 

Konícková D, Mensíková K, Tucková L, Hényková E, Strnad M, Friedecky D, Stejskal D, Matej R, Kanovsky P (2022) ‘Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status’, Biomedicines, 10(7)

Kwon H, Koh S (2020) ‘Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes’. TRANSLATIONAL NEURODEGENERATION, 9

Loeffler DA, Camp DM, Conant SB (2006) Complement activation in the Parkinson’s disease substantia Nigra: an immunocytochemical study. J Neuroinflamm 3:8

Article  Google Scholar 

Logroscino G, Marder K, Graziano J, Freyer G, Slavkovich V, LoIacono N, Cote L, Mayeux R (1997) Altered systemic iron metabolism in Parkinson’s disease. Neurology 49(3):714–717

Article  CAS  PubMed  Google Scholar 

Majerova P, Michalicova A, Cente M, Hanes J, Vegh J, Kittel A, Kosikova N, Cigankova V, Mihaljevic S, Jadhav S, Kovac A (2019) ‘Trafficking of immune cells across the blood-brain barrier is modulated by neurofibrillary pathology in tauopathies’,